RICHMOND, Va.--(BUSINESS WIRE)--Insmed Incorporated (NASDAQ: INSM) has been requested by the Italian Ministry of Health, to make its drug, IPLEX™ (rhIGFI/rhIGFBP-3), available to physicians in Italy to treat patients with Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s Disease.
